Rubin Marc — SEC Form 4 filings

SEC reporting owner CIK 1412377. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-09.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-02-07 to 2026-07-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CURIS INC (CRIS)Director610
GALECTIN THERAPEUTICS INC (GALT)Director22

Form 4 filings — Rubin Marc

FiledFormIssuerReported transactionsSource
2026-07-094CURIS INC (CRIS)Grant/award (A): 6,800 (derivative) @ $5.29EDGAR
2026-03-234CURIS INC (CRIS)Conversion (C): 26,667 · Conversion (C): 20 (derivative)EDGAR
2026-03-184CURIS INC (CRIS)Grant/award (A): 20 (derivative) · Grant/award (A): 26,667 (derivative) · Grant/award (A): 26,667 (derivative) · Grant/award (A): 26,667 (derivative)EDGAR
2025-05-224CURIS INC (CRIS)Grant/award (A): 14,400 (derivative) @ $3.13EDGAR
2025-01-304CURIS INC (CRIS)Grant/award (A): 1,600 (derivative) @ $3.13EDGAR
2025-01-274GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-05-234CURIS INC (CRIS)Grant/award (A): 4,250 (derivative) @ $11.62EDGAR
2024-02-074GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1412377 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →